Exco InTouch has introduced React, providing secure mobile communication for healthcare and biopharmaceutical applications
React is designed to improve subject recruitment, retention and compliance during clinical trials and pharmaceutical marketing studies, from delivering reminder services to patients to non-intrusive methods of promoting investigator relationships.
The company claims React has revolutionised clinical trial communication, using Short Message Service (SMS) to send scheduled, action-driven text messages directly to the mobile phone user, enhancing volunteer relationship management.
Finding good quality volunteers and patients for clinical trials is a continuing challenge and SMS helps target, identify and locate volunteers and patient populations, additionally providing a new channel to deliver timed reminders regarding screening appointments and trial prerequisites.
React allows for the customisation of mobile services and can be integrated into existing systems or delivered as a custom-made application.
Patient retention and compliance are also improved through the provision of interactive and personalised SMS messages.
React software allows selection from approved, validated, local language translations, with the capacity to insert multiple variables for personalised messages.
Seamless integration with email and total reporting facilities is available, allowing for full role and rights-based access to ensure that the right people do the right things at the right time.
React seamlessly integrates with both electronic and paper based clinical trial workflow processes, through a secure encryption of mobile user data.
Exco InTouch follows a standard quality management process to provide the highest quality technology to its clients.
Data is stored in a secure database, complying with the EU data privacy act and applicable industry legislation.
The company's computer systems are also fully validated to comply with FDA 21 CFR part 11 guidelines.
